UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF ILLINOIS
June 22, 2011
VALERIE MURPHY, PLAINTIFF,
JOHNSON & JOHNSON, ORTHO-MCNEIL PHARMACEUTICAL, INC., AND JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, LLC, DEFENDANTS.
The opinion of the court was delivered by: J. Phil Gilbert District Judge
MEMORANDUM AND ORDER
This matter comes before the Court on the parties' joint Motion to Stay (Doc. 7). Specifically, the parties ask the Court to stay this matter in light of its impending transfer to MDL No. 1943, In re Levaquin Products Liability Litigation.
When deciding whether to stay a case due to an ongoing, related MDL, district courts should consider both judicial economy and any prejudice or hardship that the parties would face as the result of a stay. Walker v. Merck & Co., Inc., No. 05-cv-360-DRH, 2005 WL 1565839, at *2 (S.D. Ill. June 22, 2005); Bd. of Trs. of Teachers' Ret. Sys. of State of Ill. v. Worldcom, Inc., 244 F. Supp. 2d 900, 905 (N.D. Ill. 2002). Here, the Court finds that it is in the interest of judicial economy to stay this matter. A stay will avoid inconsistent legal rulings and allow this case to proceed in an orderly, coordinated fashion. Moreover, because the parties agree to the terms of the instant motion, the Court can safely assume that the parties will not suffer prejudice or hardship if a stay is granted.
For the foregoing reasons, the Court GRANTS the parties' Motion to Stay (Doc. 7), whereby the Court STAYS this matter pending its transfer to MDL No. 1943, In re Levaquin Products Liability Litigation. Further, the Court ORDERS the parties to submit a joint status report in September of this year and every six months thereafter.
IT IS SO ORDERED.
J. Phil Gilbert
© 1992-2011 VersusLaw Inc.